Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Child neurodevelopment, antipsychotic exposure during pregnancy
Children and adolescents antipsychotics use anxiety disorders first-generation antipsychotics second-generation antipsychotics alcohol misuse anxiety, with autism spectrum disorder augmentation of other drug treatments rapid tranquilisation
Chloridazepoxide, alcohol withdrawal treatment
Chlorpromazine Alternative routes of administration Antipsychotics - minimum effective doses General introduction Relative adverse effects - a rough guide Antipsychotic prophylaxis Equivalent doses Quick reference for licensed maximum doses
Choice
Cholesterol Effects of antipsychotic medications on plasma lipids Biochemical and haematological effects of psychotropics
Chronic kidney disease
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula, glomerular filtration rate estimation
Citalopram as antidepressant switching antidepressants binge eating disorder use in patients with hepatic impairment
Classification of renal impairment.
Chemotherapeutic agents, psychiatric adverse effects
Chemotherapy contraindication
Childrenq11.2 deletion syndrome,821
Chloride in blood, psychotropic agent effects
Chlorprothixene, possible teratogen
Choosing between buprenorphine and methadone
chronic kidney disease (CKD), psychiatric disorders
Cimetidine, psychiatric adverse effects
Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar).
Clinical Institute Withdrawal Assessment of Alcohol Scale - Revised (CIWA-Ar) 482 GHB and GBL dependence Alcohol dependence
Clinical Opiate Withdrawal Scale (COWS) 501
Clinical Opiate Withdrawal Scale (COWS)
Clinician-patient relationship
Clinicians training in compliance therapy and adherence seeking support
clomipramine (Anafranil) serotonin reuptake inhibition in pregnancy
Clonidine, clozapine-induced hypersalivation
Clotiapine Equivalent doses Antipsychotics - minimum effective doses Site of administration of intramuscular injections
Clotting factor synthesis reduction, hepatic impairment
Clozapine augmentation
clozapine-induced GI hypomotility (CIGH) 263-266 Acting on clozapine plasma concentration results management of suspected acute CIGH risk factors clozapine rechallenge following severe constipation prevention and simple management